A detailed history of Wells Fargo & Company transactions in Seer, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 20,574 shares of SEER stock, worth $34,564. This represents 0.0% of its overall portfolio holdings.

Number of Shares
20,574
Previous 17,917 14.83%
Holding current value
$34,564
Previous $34,000 14.71%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

BUY
$1.54 - $2.09 $4,091 - $5,553
2,657 Added 14.83%
20,574 $39,000
Q4 2023

Feb 09, 2024

BUY
$1.47 - $2.22 $5,230 - $7,898
3,558 Added 24.78%
17,917 $34,000
Q3 2023

Nov 13, 2023

SELL
$2.18 - $5.52 $17,065 - $43,210
-7,828 Reduced 35.28%
14,359 $31,000
Q2 2023

Aug 15, 2023

BUY
$3.16 - $4.96 $41,446 - $65,055
13,116 Added 144.59%
22,187 $94,000
Q1 2023

May 12, 2023

BUY
$3.6 - $5.88 $32,655 - $53,337
9,071 New
9,071 $35,000
Q3 2022

Nov 14, 2022

SELL
$7.7 - $13.31 $7,823 - $13,522
-1,016 Reduced 78.82%
273 $2,000
Q2 2022

Aug 12, 2022

SELL
$6.72 - $16.07 $27,216 - $65,083
-4,050 Reduced 75.86%
1,289 $12,000
Q1 2022

May 16, 2022

SELL
$11.88 - $23.4 $204,728 - $403,252
-17,233 Reduced 76.35%
5,339 $81,000
Q4 2021

Feb 14, 2022

BUY
$21.08 - $38.51 $321,259 - $586,892
15,240 Added 207.86%
22,572 $515,000
Q3 2021

Nov 15, 2021

BUY
$27.67 - $45.04 $2,877 - $4,684
104 Added 1.44%
7,332 $253,000
Q2 2021

Aug 16, 2021

SELL
$28.75 - $56.92 $35,851 - $70,979
-1,247 Reduced 14.71%
7,228 $237,000
Q1 2021

May 13, 2021

BUY
$38.67 - $84.06 $327,728 - $712,408
8,475 New
8,475 $424,000

Others Institutions Holding SEER

About Seer, Inc.


  • Ticker SEER
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 58,566,500
  • Market Cap $98.4M
  • Description
  • Seer, Inc., a life sciences company, engages in developing and commercializing products to decode the secrets of the proteome. It develops Proteograph Product Suite, an integrated solution that comprises consumables, an automation instrumentation, and software that allows researchers to conduct proteomic studies in therapeutic and diagnostic res...
More about SEER
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.